UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 90

Sortiert nach

Individual Fluorouracil Dose Adjustment Based on Pharmacokinetic Follow-Up Compared With Conventional Dosage: Results of a Multicenter Randomized Trial of Patients With Metastatic Colorectal Cancer

Journal of clinical oncology, 2008-05, Vol.26 (13), p.2099-2105

2008

Volltextzugriff (PDF)

Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC Trial

European urology, 2022-03, Vol.81 (3), p.234-240

2022

Volltextzugriff (PDF)

Very Long‐Term Complete Remission Can Be Achieved in Men With High‐Risk Localized Prostate Cancer and a Very High PSA Value: An Analysis of the GETUG 12 Phase 3 Trial

Clinical genitourinary cancer, 2023-10, Vol.21 (5), p.615.e1-615.e8

2023

Volltextzugriff (PDF)

Nivolumab‐induced bullous pemphigoid after radiotherapy and abscopal effect

Australasian journal of dermatology, 2019-08, Vol.60 (3), p.e235-e236

2019

Volltextzugriff (PDF)

Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial

The lancet oncology, 2011-07, Vol.12 (7), p.673-680

2011

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer

Journal of clinical oncology, 2016-08, Vol.34 (22), p.2636-2643

2016

Volltextzugriff (PDF)

Androgen deprivation therapy (ADT) plus docetaxel (D) versus ADT alone for hormone-naïve metastatic prostate cancer (PCa): Long-term analysis of the GETUG-AFU 15 phase III trial

Journal of clinical oncology, 2015-03, Vol.33 (7_suppl), p.140-140

2015

Volltextzugriff (PDF)

Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors

Pharmaceutical research, 2020-07, Vol.37 (7), p.147, Article 147

2020

Volltextzugriff (PDF)

Randomized Study of Intravenous versus Subcutaneous Interleukin-2, and IFNα in Patients with Good Prognosis Metastatic Renal Cancer

Clinical cancer research, 2008-09, Vol.14 (18), p.5907-5912

2008

Volltextzugriff (PDF)

Therapeutic Drug Monitoring of Carboplatin in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors: Pharmacokinetic Results of a Phase II Multicenter Study

Clinical cancer research, 2017-12, Vol.23 (23), p.7171-7179

2017

Volltextzugriff (PDF)

Measurement-based entanglement of semiconductor spin qubits

Physical review. B, 2024-07, Vol.110 (3), Article 035304

2024

Volltextzugriff (PDF)

Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study

The lancet oncology, 2022-02, Vol.23 (2), p.248-258

2022

Volltextzugriff (PDF)

Simulation of Measurement-Based Entanglement in Silicon Spin Qubits

Delva, Remy L

2024

Volltextzugriff (PDF)

Multicentric phase II trial of TI‐CE high‐dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors

Cancer medicine (Malden, MA), 2021-04, Vol.10 (7), p.2250-2258

2021

Volltextzugriff (PDF)

Impact of Iron-Deficiency Management on Quality of Life in Patients with Cancer: A Prospective Cohort Study (CAMARA Study)

The oncologist (Dayton, Ohio), 2022-04, Vol.27 (4), p.328-333

2022

Volltextzugriff (PDF)

Randomized Trial Comparing Bleomycin/Etoposide/Cisplatin With Alternating Cisplatin/Cyclophosphamide/Doxorubicin and Vinblastine/Bleomycin Regimens of Chemotherapy for Patients With Intermediate- and Poor-Risk Metastatic Nonseminomatous Germ Cell Tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP

Journal of clinical oncology, 2008-01, Vol.26 (3), p.421-427

2008

Volltextzugriff (PDF)

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial

The lancet oncology, 2013-02, Vol.14 (2), p.149-158

2013

Volltextzugriff (PDF)

Optimal duration of adjuvant chemotherapy for high-risk node-negative (N–) breast cancer patients: 6-year results of the prospective randomised multicentre phase III UNICANCER-PACS 05 trial (UCBG-0106)

European journal of cancer (1990), 2017-07, Vol.79, p.166-175

2017

Volltextzugriff (PDF)

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial

The lancet oncology, 2015-07, Vol.16 (7), p.787-794

2015

Volltextzugriff (PDF)

Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial

European urology, 2018-05, Vol.73 (5), p.696-703

2018

Volltextzugriff (PDF)

Unexpected response to cisplatin rechallenge after immune checkpoint inhibitors in patients with metastatic urothelial carcinoma refractory to platinum regimen

European journal of cancer (1990), 2018-11, Vol.104, p.236-238

2018

Volltextzugriff (PDF)

Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis : Results of a randomized controlled trial

Cancer, 2007-12, Vol.110 (11), p.2468-2477

2007

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(40)
Humans
(39)
Oncology
(34)
Middle Aged
(32)
Aged
(31)
Male
(27)
Female
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(19)
Adult
(18)
Life Sciences
(16)
Chemotherapy
(15)
Treatment Outcome
(14)
Aged, 80 And Over
(12)
Tumors
(12)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(11)
Biological And Medical Sciences
(11)
Disease-Free Survival
(11)
Medical Sciences
(11)
Neoplasm Metastasis
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial

Individual Fluorouracil Dose Adjustment Based on Pharmacokinetic Follow-Up Compared With Conventional Dosage: Results of a Multicenter Randomized Trial of Patients With Metastatic Colorectal Cancer

Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC Trial

Very Long‐Term Complete Remission Can Be Achieved in Men With High‐Risk Localized Prostate Cancer and a Very High PSA Value: An Analysis of the GETUG 12 Phase 3 Trial

Nivolumab‐induced bullous pemphigoid after radiotherapy and abscopal effect

Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial

Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer

Androgen deprivation therapy (ADT) plus docetaxel (D) versus ADT alone for hormone-naïve metastatic prostate cancer (PCa): Long-term analysis of the GETUG-AFU 15 phase III trial

Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors

Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d’Etude des Tumeurs Uro-Génitales)

Randomized Study of Intravenous versus Subcutaneous Interleukin-2, and IFNα in Patients with Good Prognosis Metastatic Renal Cancer

Therapeutic Drug Monitoring of Carboplatin in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors: Pharmacokinetic Results of a Phase II Multicenter Study

Measurement-based entanglement of semiconductor spin qubits

Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study

Simulation of Measurement-Based Entanglement in Silicon Spin Qubits

Multicentric phase II trial of TI‐CE high‐dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors

Impact of Iron-Deficiency Management on Quality of Life in Patients with Cancer: A Prospective Cohort Study (CAMARA Study)

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial

Optimal duration of adjuvant chemotherapy for high-risk node-negative (N–) breast cancer patients: 6-year results of the prospective randomised multicentre phase III UNICANCER-PACS 05 trial (UCBG-0106)

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial

Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial

Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial

Unexpected response to cisplatin rechallenge after immune checkpoint inhibitors in patients with metastatic urothelial carcinoma refractory to platinum regimen

Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis : Results of a randomized controlled trial

Suchergebnisse filtern